Twist Bioscience Corporation (FRA:0ME)

Germany flag Germany · Delayed Price · Currency is EUR
21.98
-0.26 (-1.17%)
At close: Nov 21, 2025
-42.25%
Market Cap 1.72B
Revenue (ttm) 320.95M
Net Income (ttm) -66.20M
Shares Out n/a
EPS (ttm) -1.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 44
Open 22.09
Previous Close 22.24
Day's Range 21.98 - 22.17
52-Week Range 20.36 - 51.86
Beta n/a
RSI 36.82
Earnings Date Nov 17, 2025

About Twist Bioscience

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Employees 979
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 0ME
Full Company Profile

Financial Performance

In 2025, Twist Bioscience's revenue was $376.57 million, an increase of 20.32% compared to the previous year's $312.97 million. Losses were -$77.67 million, -62.79% less than in 2024.

Financial numbers in USD Financial Statements

News

There is no news available yet.